Intraocular surgery under systemic interferon-alpha therapy in ocular Adamantiades-Behçe's disease

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 245, Issue 11, 2007, Pages 1617-1621

  Krause, Lothar ^a   Altenburg, Andreas ^b   Bechrakis, Nikolaos E ^a   Willerding, Gregor ^a   Zouboulis, Christos C ^b   Foerster, Michael H ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b DESSAU MEDICAL CENTER   (Germany)

Author keywords

Intraocular surgery; Morbus Adamantiades Beh et; Uveitis; Vasculitis

Indexed keywords

ALPHA2A INTERFERON; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CYCLOSPORIN A; DEXAMETHASONE; GENTAMICIN; PREDNISOLONE; STEROID;

ADAMANTIADES BEHCET DISEASE; ADHESION; ADULT; ARTICLE; CATARACT EXTRACTION; CILIARY DISK; CLINICAL ARTICLE; CLINICAL TRIAL; CONSERVATIVE TREATMENT; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; EYE DISEASE; EYE INFLAMMATION; EYE SURGERY; FEMALE; FOLLOW UP; HUMAN; MALE; MONOTHERAPY; OPTIC NERVE ATROPHY; PHACOEMULSIFICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RELIABILITY; RETINA MACULA EDEMA; SAFETY; SYSTEMIC THERAPY; TRABECULECTOMY; TREATMENT FAILURE; VISUAL ACUITY; VITRECTOMY;

ADULT; BEHCET SYNDROME; COMBINED MODALITY THERAPY; HUMANS; INJECTIONS, SUBCUTANEOUS; INTERFERON ALFA-2A; MIDDLE AGED; PHACOEMULSIFICATION; PROSPECTIVE STUDIES; SILICONE OILS; SULFUR HEXAFLUORIDE; TRABECULECTOMY; TREATMENT OUTCOME; VISUAL ACUITY; VITRECTOMY;

EID: 34848899838     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-007-0577-6     Document Type: Article

References (25)

1. Adamantiades B (1931) Sur un cas d'iritis à hypopyon recidivant. Ann Oculist 168:271-278
2. Behçet H (1937) Über rezidivierende, aphtöse, durch ein Virus verursachte Geschwüre im Mund, am Auge und an den Genitalien. Dermatol Wochenschr 105:1152-1157
3. Rizzi R, Bruno S, Dammacco R (1997) Behcet's disease: An immune-mediated vasculitis involving vessels of all sizes. Int J Clin Lab Res 27:225-232
4. Yazici H, Barnes CG (1991) Practical treatment recommendations for pharmacotherapy of Behcet's syndrome. Drugs 42:796-804
5. Zouboulis CC, Orfanos CE (1998) Treatment of Adamantiades-Behcet disease with systemic interferon alfa. Arch Dermatol 134:1010-1016
6. Krause L (2005) [Adamantiades-Behcet's disease]. Ophthalmologe 102:329-334
7. Zouboulis CC (1999) Epidemiology of Adamantiades-Behcet's disease. Ann Med Interne (Paris) 150:488-498
8. Tugal-Tutkun I, Onal S, Altan-Yaycioglu R, Huseyin Altunbas H, Urgancioglu M (2004) Uveitis in Behcet disease: An analysis of 880 patients. Am J Ophthalmol 138:373-380
9. Bang D (1997) Treatment of Behcet's disease. Yonsei Med J 38:401-410
10. Hamuryudan V, Ozyazgan Y, Hizli N, Mat C, Yurdakul S et al (1997) Azathioprine in Behcet's syndrome: Effects on long-term prognosis. Arthritis Rheum 40:769-774
11. Yazici H, Pazarli H, Barnes CG, Tuzun Y, Ozyazgan Y et al (1990) A controlled trial of azathioprine in Behcet's syndrome. N Engl J Med 322:281-285
12. Alpsoy E, Durusoy C, Yilmaz E, Ozgurel Y, Ermis O et al (2002) Interferon alfa-2a in the treatment of Behcet disease: A randomized placebo-controlled and double-blind study. Arch Dermatol 138:467-471
13. Kotter I, Zierhut M, Eckstein AK, Vonthein R, Ness T et al (2003) Human recombinant interferon alfa-2a for the treatment of Behcet's disease with sight threatening posterior or panuveitis. Br J Ophthalmol 87:423-431
14. Kotter I, Eckstein AK, Stubiger N, Zierhut M (1998) Treatment of ocular symptoms of Behcet's disease with interferon alpha 2a: A pilot study. Br J Ophthalmol 82:488-494
15. Krause L, Turnbull JR, Torun N, Pleyer U, Zouboulis CC, Foerster MH (2003) Interferon alfa-2a in the treatment of ocular Adamantiades-Behcet's disease. Adv Exp Med Biol 528:511-519
16. Tugal-Tutkun I, Guney-Tefekli E, Urgancioglu M (2006) Results of interferon-alfa therapy in patients with Behcet uveitis. Graefes Arch Clin Exp Ophthalmol 244(12):1692-1695
17. Wechsler B, Bodaghi B, Huong DL, Fardeau C, Amoura Z et al (2000) Efficacy of interferon alfa-2a in severe and refractory uveitis associated with Behcet's disease. Ocul Immunol Inflamm 8:293-301
18. Ozdemir O, Erkam N, Bakkaloglu A (1988) Results of pars plana vitrectomy in Behcet's disease. Ann Ophthalmol 20:35-38
19. Ozerturk Y, Bardak Y, Durmus M (2001) Vitreoretinal surgery in Behcet's disease with severe ocular complications. Acta Ophthalmol Scand 79:192-196
20. Krause L, Hoffmann F, Zouboulis CC, Foerster MH (2003) Vitrectomy and trabeculectomy combined with interferon alpha treatment in Adamantiades-Behcet's disease: A case report. Graefes Arch Clin Exp Ophthalmol 241:871-874
21. Sullu Y, Oge I, Erkan D (2000) The results of cataract extraction and intraocular lens implantation in patients with Behcet's disease. Acta Ophthalmol Scand 78:680-683
22. Kadayifcilar S, Gedik S, Eldem B, Irkec M (2002) Cataract surgery in patients with Behcet's disease. J Cataract Refract Surg 28:316-320
23. Matsuo T, Takahashi M, Inoue Y, Egi K, Kuwata Y, Yamaoka A (2001) Ocular attacks after phacoemulsification and intraocular lens implantation in patients with Behcet disease. Ophthalmologica 215:179-182
24. Berker N, Soykan E, Elgin U, Ozkan SS (2004) Phacoemulsification cataract extraction and intraocular lens implantation in patients with Behcet's disease. Ophthalmic Surg Lasers Imaging 35:215-218
25. Yalvac IS, Sungur G, Turhan E, Eksioglu U, Duman S (2004) Trabeculectomy with mitomycin-C in uveitic glaucoma associated with Behcet disease. J Glaucoma 13:450-453